| Mr Scott Scott Thurston, | |
|
23625 Wr Holman Hwy # 68, Monterey, CA 93940-5902 | |
| (831) 625-4515 | |
| (831) 625-4966 |
| Full Name | Mr Scott Scott Thurston |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 23625 Wr Holman Hwy # 68, Monterey, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073366308 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 77095 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Scott Scott Thurston, 23625 Wr Holman Hwy # 68, Monterey, CA 93940-5902 Ph: (831) 625-4515 | Mr Scott Scott Thurston, 23625 Wr Holman Hwy # 68, Monterey, CA 93940-5902 Ph: (831) 625-4515 |
News Archive
George Washington University researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.
PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.
Medical centers, hospitals, clinics and other treatment sites across the country are actively enrolling Americans with the hepatitis C virus (HCV) in a nationwide study that will for the first time determine which of the two FDA-approved pegylated interferon therapy regimens offers patients the best chance to eliminate the virus.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has commenced a randomized, double-blind, placebo-controlled Pilot Study of up to 165 persons who have type 2 diabetes, the most common form of diabetes.
› Verified 7 days ago
Vy Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23625 Holman Hwy, Monterey, CA 93940 Phone: 831-624-5311 | |
Dr. Erin Crisson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23625 Holman Hwy, Monterey, CA 93940 Phone: 831-624-5311 | |
Lynn Denice Hendrick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23625 Holman Hwy, Monterey, CA 93940 Phone: 831-625-4906 | |
Patricia New, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Po Box Hh, Monterey, CA 93942 Phone: 831-625-4515 Fax: 831-625-4966 | |
Mina Nekomoto, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 416 Alvarado St, Monterey, CA 93940 Phone: 831-644-9057 | |
Dr. Susan Carol Miller, PHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Munras Ave Ste 10, Monterey, CA 93940 Phone: 831-333-0755 Fax: 831-333-0759 |